A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics

Clinical trial NCT02996838 · UNKNOWN

Trial details

NCT number: NCT02996838
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2017-05-11
Primary completion: 2020-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.